Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer. “When I turned 55—I’m now 70—my wife, Alice, said to me, ‘What do you want to do for...
Tag: <span>Prostate cancer</span>
Post
How a simple urine test can now help doctors spot signs of prostate cancer with 98 per cent accuracy
Scientists claim that the test could prevent 41 per cent of unnecessary biopsies Symptoms of prostate cancer only tend to arise when tumour has grown large Men become eligible for the test if they have been identified as being at risk It is the most common form of cancer found in men in Britain, with...
Post
Cell death linked to tumor growth in prostate cancer patients
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body’s natural process for removing dead and dying cells can actually fuel tumor growth. A new University of Michigan study identifies...
Post
Researchers zero in on molecular fingerprint for prostate cancer
Six cancers that claim more than 23,000 Australian lives each year1 should be prioritised for research that makes it possible to identify the molecular fingerprint of the tumour and improve survival, according to a landmark report launched today. “Cancer Biomarkers in Australia” by the Sansom Institute for Health Research at the University of South Australia (UniSA)...
Post
Tapeworm drug fights prostate cancer
Karl-Henning Kalland’s research group has done experiments with hundreds of drugs to fight cancer. Cancer researchers at the University of Bergen (UiB) in Norway have in the recent years experienced with hundreds of known drugs, to see how they influence cancer cells. Recently they found that a substance in medicine against parasites like Giardia...
Post
Preclinical study in prostate cancer shows that virus-based drug candidate may improve anticancer vaccination
Andrei Gudkov, PhD, Senior Vice President of Basic Science and the Garman Family Chair in Cell Stress Biology at Roswell Park Cancer Institute. One of the most important areas of cancer research today involves efforts to expand the benefits of immunotherapy to more patients. Research conducted by scientists at Roswell Park Cancer Institute in...
Post
Clinical trial hopes to provide less toxic treatment for prostate cancer
Dr. Gurkamal Chatta with his patient. Over the last decade, immunotherapy has emerged as one of the most promising and innovative fields in oncology. The goal of immunotherapy is to help a patient’s own immune system fight cancer. A major breakthrough came in 2010, when the FDA approved the first cancer-treatment vaccine, sipuleucel-T (brand...
Post
Recurrence of prostate cancer could be reduced thanks to exciting new discovery
Ground breaking research could reduce the recurrence of prostate cancer in males, a new study in the journal Nature Communications reports. During this in depth study, an international team of researchers led by British scientists investigated the impact of anti-hormone therapy on samples taken from patients with prostate cancer. Anti-hormone therapy is a commonly prescribed treatment for cancer of...
Post
New Study Offers Support for Prostate Testing
For men who are weighing the pros and cons of prostate cancer screening, a new study strengthens the evidence that testing can reduce deaths from this cancer, something two earlier large landmark clinical trials appeared to reach different conclusions about. The findings do not resolve many of the questions that remain about prostate cancer screening,...
Post
Prostate cancer testing: has the bubble burst?
In 2010, I wrote a free book on prostate cancer testing with two colleagues, Alex Barratt (an epidemiologist) and Martin Stockler (a clinical oncologist), Let sleeping dogs lie? What men should know before getting tested for prostate cancer. It has been downloaded just short of 38,000 times, the highest of any item in Sydney University’s open access...